The impact of the resolution of COVID pandemic on willingness to participate in a clinical drug trial (Trial Drug), in a study where biological samples are collected (Trial Sample), or in a study that included colonoscopy (Trial Scope) The categories refer to all participants, those who were unlikely to participate pre-pandemic, those who were likely to participate pre-pandemic, and those who were neither unlikely or likely to participate.